Please enable JavaScript.
Coggle requires JavaScript to display documents.
Healthcare in India (Way forward (licensing mechanisms for tiered pricing…
Healthcare in India
Background
Lancet study on quality and accessibility of healthcare: Indian rank 145/195> behind Bangladesh, SL, Bhutan
-
Price control by Govt
-
-
Issues
challenging environment for the medical devices industry.. Patents not benefitted, Inhibits Innovation
price ceilings do not tackle
the real reasons that contribute to high prices for medical treatment
Because: WHO--> more than 50% of the end price of medicines is contributed by
components other than the manufacturer’s selling price
-
Price cap doesnt consider other factors like doctor fees, room rents, drug charges, hospital charges
-
-
Way forward
-
-
building competency
in health technology assessment (HTA) to bring in low cost products and incentivising drug firms for more innovation
-
-
-
promise of universal, affordable, and accessible healthcare in a welfare state.
-